116 related articles for article (PubMed ID: 7874773)
1. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T
Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773
[TBL] [Abstract][Full Text] [Related]
2. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis.
Koper NP; Thomas CM; Massuger LF; Segers MF; Kiemeney LA; Verbeek AL
Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):617-23. PubMed ID: 9298352
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA.
Lynch DM; Rogers PE; Love JC; Salkas MJ; Skarphol KA; Gross ME; Lu MG; Petrides VH; Bruzek DJ; Cox JL; Jones KA; Kelley CA; Chan DW
Tumour Biol; 1998; 19(6):421-38. PubMed ID: 9817970
[TBL] [Abstract][Full Text] [Related]
4. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
Vessella RL; Noteboom J; Lange PH
Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
[TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of the Abbott IMx CA 15-3 assay.
van Kamp GJ; Bon GG; Verstraeten RA; Lynch D; Krikau M; Flückiger J; Ruibal A; Kenemans P
Clin Chem; 1996 Jan; 42(1):28-33. PubMed ID: 8565228
[TBL] [Abstract][Full Text] [Related]
7. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
[TBL] [Abstract][Full Text] [Related]
8. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum.
Kenemans P; van Kamp GJ; Oehr P; Verstraeten RA
Clin Chem; 1993 Dec; 39(12):2509-13. PubMed ID: 8252723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Abbott IMx fluorescence polarization immunoassay and the bio-rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography.
Donnelly JG; Pronovost C
Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():194-8. PubMed ID: 10735363
[TBL] [Abstract][Full Text] [Related]
10. IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration.
Mogensen O; Mogensen B
Scand J Clin Lab Invest; 1995 Jul; 55(4):289-94. PubMed ID: 7569730
[TBL] [Abstract][Full Text] [Related]
11. Comparison of methods for measuring free thyroxin in nonthyroidal illness.
Wong TK; Pekary AE; Hoo GS; Bradley ME; Hershman JM
Clin Chem; 1992 May; 38(5):720-4. PubMed ID: 1582025
[TBL] [Abstract][Full Text] [Related]
12. Abbott IMx and serono MAIAclone assays compared for lutropin determinations in urine.
Weiss P; Zech H; Schönholzer HP; Fritzsche H
Clin Chem; 1992 Nov; 38(11):2280-3. PubMed ID: 1424125
[TBL] [Abstract][Full Text] [Related]
13. The second generation CA 125 assays.
Kenemans P; Verstraeten AA; van Kamp GJ; von Mensdorff-Pouilly S
Ann Med; 1995 Feb; 27(1):107-13. PubMed ID: 7741988
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
Yedema KA; Thomas CM; Segers MF; Doesburg WH; Kenemans P
Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):245-52. PubMed ID: 1294413
[TBL] [Abstract][Full Text] [Related]
15. Automated enzyme immunoassay for lutropin with the Abbott IMx analyzer.
Ford KA; Baker HN; Baar JG; Balay D; Marlewski D; Venetucci M; Ogunro EA
Clin Chem; 1989 Dec; 35(12):2333-5. PubMed ID: 2686863
[TBL] [Abstract][Full Text] [Related]
16. Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
Bon GG; von Mensdorff-Pouilly S; Kenemans P; van Kamp GJ; Verstraeten RA; Hilgers J; Meijer S; Vermorken JB
Clin Chem; 1997 Apr; 43(4):585-93. PubMed ID: 9105258
[TBL] [Abstract][Full Text] [Related]
17. Immunoassays for quantifying choriogonadotropin compared for assay performance and clinical application.
Witherspoon LR; Shuler SE; Joseph GF; Baird EF; Neely HR; Sonnemaker RE
Clin Chem; 1992 Jun; 38(6):887-94. PubMed ID: 1375877
[TBL] [Abstract][Full Text] [Related]
18. Analytical and clinical evaluation of a procedure for measuring CA 15-3 in the IMx analyser.
Ortega MD; Maestro ML; Encabo G; Varón C; Allende MT; Martinez I; Palacios G
Tumour Biol; 1996; 17(2):110-6. PubMed ID: 8658013
[TBL] [Abstract][Full Text] [Related]
19. Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.
Davelaar EM; Schutter EM; von Mensdorff-Pouilly S; van Kamp GJ; Verstraeten RA; Kenemans P
Ann Clin Biochem; 2003 Nov; 40(Pt 6):663-73. PubMed ID: 14629806
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Escudero JM; Auge JM; Filella X; Torne A; Pahisa J; Molina R
Clin Chem; 2011 Nov; 57(11):1534-44. PubMed ID: 21933899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
